Saturday, January 26, 2019

Open-label Use of Highly Purified CBD (Epidiolex®) in Patients with CDKL5 Deficiency Disorder and Aicardi, Dup15q, and Doose Syndromes


Latest published work on the effects of epdiolex on Dup15q yndrome

No comments:

Post a Comment